Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTI-2040 + Docetaxel + Prednisone in HRPC
NCT00087165Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jan 2005
- Primary completion
- Sep 2006
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of GTI-2040 in prostate cancer (PCa), sponsored by University Health Network. Started Jan 2005; status: completed.
02
Drugs
GTI-2040
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00087165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087165.